Phase I Pharmacokinetic Study of Niraparib in Chinese Patients with Epithelial Ovarian Cancer

LESSONS LEARNED: Pharmacokinetics characteristics of niraparib in Chinese patients were similar to those in white patients. Niraparib could be well tolerated by Chinese patients, and adverse events were manageable in this study. Population pharmacokinetics analysis indicated that baseline body weigh...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Oncologist
Κύριοι συγγραφείς: Zhang, Jian, Zheng, Hong, Gao, Yunong, Lou, Ge, Yin, Rutie, Ji, Dongmei, Li, Wenhua, Wang, Wei, Xia, Bairong, Wang, Danqing, Hou, Jianmei, Yan, James, Hei, Yongjiang, Zhang, Zhi‐Yi, Milton, Ashley, Wu, Xiaohua
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: John Wiley & Sons, Inc. 2019
Θέματα:
Clinical Trial Results
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6964144/
https://ncbi.nlm.nih.gov/pubmed/31439812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0565
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια